Nel (NEL) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
19 Jan, 2026Executive summary
Q3 2024 revenue reached NOK 366 million, up 21% year-over-year, driven by strong alkaline segment performance, while PEM segment revenues declined 40% year-over-year due to project timing and low shipments.
EBITDA was NOK -90 million, down from NOK -60 million to -62 million last year, as positive alkaline contribution was offset by negative PEM performance; management expects a significantly better Q4 due to licensing revenue and improved segment performance.
Order intake was NOK 161 million, down 52% year-over-year, with order backlog at NOK 1,872–1,900 million, reflecting delayed FIDs and market softness.
Cash reserves remain strong at NOK 1,941 million, with no need for additional funding as CapEx is set to decrease by 50% in 2025.
Cavendish Hydrogen ASA was spun off and separately listed in June 2024, with prior period figures restated to reflect discontinued operations.
Financial highlights
Alkaline segment revenues grew 37% quarter-on-quarter and 54% year-over-year, with positive EBITDA driven by higher volumes and improved cost structure.
PEM segment revenues fell 40% year-over-year, with low cost absorption and EBITDA, but performance is expected to improve as the 500 MW production line nears completion.
EBITDA margin was -24% in Q3 2024, down from -20% in Q3 2023, mainly due to weaker PEM division results.
Net loss for Q3 2024 was NOK -115 million, compared to NOK -167 million in Q3 2023.
Net cash flow from operating activities improved to NOK -47 million from NOK -136 million in Q3 2023.
Outlook and guidance
Management anticipates a much stronger Q4, supported by licensing revenue from Reliance and improved segment performance.
CapEx will be reduced by 50% in 2025, with focus on next-generation technology development and cash conservation.
Market is showing early signs of recovery, with high-quality projects expected to reach FID in coming quarters as regulatory clarity improves in the EU and US.
Production output and staffing will be aligned with real market demand.
Top-20 alkaline and PEM prospects represent over 6 GW of potential capacity.
Latest events from Nel
- Order intake surged despite heavy impairments and revenue decline, with new technology set for 2026 launch.NEL
Q4 202526 Feb 2026 - Revenue fell 44% but record PEM order intake and cost cuts support strong cash reserves.NEL
Q1 20253 Feb 2026 - Revenue down 10%, net loss narrowed, and major strategic deals followed Cavendish spin-off.NEL
Q2 20243 Feb 2026 - Strong regulatory tailwinds and new products position Cavendish for major hydrogen mobility growth.NEL
Status Update1 Feb 2026 - EBITDA improved, revenue rose, and order intake increased, but backlog and cash declined.NEL
Q4 202416 Dec 2025 - Revenue down 48% and order intake down 74%, but strong cash and tech progress support outlook.NEL
Q2 202516 Nov 2025 - Revenue and orders fell, but losses narrowed and cost controls strengthened financial resilience.NEL
Q3 202530 Oct 2025